MIATA WALLACE: Open Payments
NPI 1013656990 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 22 payments from 14 companies in 2025. Trend: 2023 $589 · 2024 $330 · 2025 $622
Food & beverage: $422Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 4 | $237 |
| Grifols USA, LLC | 6 | $136 |
| Baxter Healthcare | 1 | $41 |
| ABIOMED | 1 | $38 |
| United Therapeutics Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| GENZYME CORPORATION | 1 | $16 |
| JAZZ PHARMACEUTICALS INC. | 1 | $16 |
Products named: LUMRYZ, Prolastin-C Liquid, Hillrom - Vest System Model 105 Home Care, GLASSIA, Ohtuvayre, NUCALA, DUPIXENT, XYWAV.
Industry payments across NE — which companies pay providers there.
